ERBB2 and glioblastoma: One group of researchers discovered that ErbB2 protein expression was overexpressed in a substantial proportion of GBM samples and employed ErbB2/HER2-specific NK cells to target GBM, proposing “CAR-NK” cells—human NK cells that express ErbB2-specific chimeric antigen receptors [251].